Rimei Nishimura Selected Research

Rimei Nishimura Research Topics

Disease

40	Type 2 Diabetes Mellitus (MODY) 01/2024 - 02/2005
19	Hypoglycemia (Reactive Hypoglycemia) 04/2024 - 07/2010
17	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2024 - 07/2003
10	Hyperglycemia 08/2023 - 05/2008
5	Diabetic Nephropathies (Diabetic Nephropathy) 01/2023 - 10/2019
5	Albuminuria 01/2022 - 10/2007
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 11/2006
5	Obesity 07/2020 - 03/2006
4	Diabetes Complications 04/2022 - 05/2008
4	Body Weight (Weight, Body) 01/2021 - 03/2016
4	Hypercholesterolemia 03/2016 - 06/2011
3	Neoplasms (Cancer) 01/2024 - 01/2021
3	Atherosclerosis 07/2023 - 09/2007
3	Hypertension (High Blood Pressure) 03/2020 - 10/2007
2	Fibrosis (Cirrhosis) 01/2022 - 10/2019
2	Non-alcoholic Fatty Liver Disease 01/2021 - 09/2020
2	Chronic Renal Insufficiency 12/2018 - 01/2012
2	Insulin Resistance 12/2018 - 09/2017
2	Overweight 01/2016 - 09/2012
2	Abdominal Obesity 03/2014 - 10/2007
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2014 - 07/2003
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 04/2024
1	Diabetic Angiopathies (Diabetic Angiopathy) 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Macular Edema 01/2022
1	Tooth Loss 01/2021
1	Proteinuria 01/2021
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021
1	Fatty Liver 09/2020
1	Hypoalbuminemia 02/2020
1	Infections 10/2016
1	Cerebral Infarction 03/2015

Drug/Important Bio-Agent (IBA)

32	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 03/2006
14	Insulin (Novolin)FDA Link 04/2024 - 03/2006
10	Hypoglycemic Agents (Hypoglycemics)IBA 06/2023 - 06/2011
6	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 04/2024 - 09/2007
6	Blood Glucose (Blood Sugar)IBA 05/2018 - 10/2007
5	insulin degludecIBA 03/2021 - 10/2016
4	rho-Associated KinasesIBA 04/2024 - 10/2019
4	HDL CholesterolIBA 07/2023 - 09/2008
4	Metformin (Glucophage)FDA LinkGeneric 06/2023 - 05/2019
3	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2024 - 10/2022
3	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2021 - 11/2012
3	alogliptinIBA 01/2021 - 09/2014
3	AlbuminsIBA 09/2020 - 03/2006
3	Insulin Glargine (Lantus)FDA Link 02/2020 - 07/2012
3	empagliflozinIBA 10/2019 - 01/2015
3	Long-Acting Insulin (Insulin, Long Acting)FDA Link 09/2017 - 07/2012
3	Insulin Detemir (Levemir)FDA Link 09/2017 - 07/2012
3	Pravastatin (Pravachol)FDA LinkGeneric 03/2015 - 06/2011
3	Sitagliptin Phosphate (Januvia)FDA Link 12/2014 - 08/2012
3	Hemoglobins (Hemoglobin)IBA 06/2011 - 03/2006
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2023 - 01/2022
2	Monomeric GTP-Binding ProteinsIBA 01/2023 - 10/2019
2	Glucagon (Glukagon)FDA Link 04/2022 - 01/2020
2	Alanine Transaminase (SGPT)IBA 01/2021 - 12/2018
2	EnzymesIBA 09/2020 - 09/2007
2	Protein Isoforms (Isoforms)IBA 01/2020 - 03/2014
2	LipidsIBA 01/2019 - 03/2016
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 01/2012
2	Biphasic InsulinsIBA 09/2017 - 05/2008
2	oxidized low density lipoproteinIBA 03/2016 - 05/2013
2	ORALIT (ORS)IBA 01/2016 - 09/2012
2	AdiponectinIBA 03/2014 - 05/2007
2	Acarbose FDA LinkGeneric 03/2011 - 02/2005
1	Sodium-Glucose Transporter 2IBA 08/2023
1	CholesterolIBA 07/2023
1	Therapeutic UsesIBA 06/2023
1	SymportersIBA 10/2022
1	SodiumIBA 10/2022
1	CarbohydratesIBA 04/2022
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2022
1	Protein Kinases (Protein Kinase)IBA 01/2022
1	Pioglitazone (Actos)FDA Link 01/2022
1	CytokinesIBA 01/2022
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022
1	Streptozocin (Streptozotocin)FDA Link 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	Myosin-Light-Chain PhosphataseIBA 01/2021
1	fasudil (AT 877)IBA 01/2021
1	InsulinsIBA 01/2021
1	trelagliptinIBA 11/2019
1	Nonesterified Fatty Acids (NEFA)IBA 10/2019
1	Ketone BodiesIBA 10/2019
1	LinagliptinIBA 05/2019
1	Antihypertensive Agents (Antihypertensives)IBA 01/2019
1	Fibric Acids (Fibrates)IBA 01/2019
1	BiguanidesIBA 09/2017
1	ThiazolidinedionesIBA 09/2017
1	1,5- anhydro- 1- (5- (4- ethoxybenzyl)- 2- methoxy- 4- methylphenyl)- 1- thioglucitolIBA 01/2016
1	Triglycerides (Triacylglycerol)IBA 03/2015

Therapy/Procedure

14	Glycemic Control 04/2024 - 05/2008
14	Therapeutics 01/2024 - 07/2003
5	Drug Therapy (Chemotherapy) 10/2023 - 03/2018
2	Renal Replacement Therapy (Therapies, Renal Replacement) 09/2007 - 07/2003
1	Nutrition Therapy (Medical Nutrition Therapy) 04/2022
1	Exercise Therapy (Therapy, Exercise) 04/2022
1	Secondary Prevention 01/2022
1	Oral Administration 10/2019